Drawing for SUNYOKON

USPTO serial 79264756

SUNYOKON

Reviewed by CopyMark Law Group

Reg. 6021223Status 709
Filing date
Status date
Registration date
Mar 31, 2020
Examiner
CARR, PATRICK C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SUNYOKON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nyall Engfield

16950 Via de Santa Fe, 5404-107Rancho Santa Fe, CA 92067UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medicinal herbs in dried or preserved form; germicides; medicinal herbs; mineral food supplements; nutritional supplements; reishi mushroom (ganoderma lucidum) dietary supplements in the form of capsule, powder, liquid, granular or jelly; mothproofing preparations; cotton for medical purposes; teeth filling material; diapers for petsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2026C71TCANCELLED SECTION 71—
Mar 31, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 29, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 7, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 7, 2020FIMPFINAL DISPOSITION PROCESSED—
Jun 30, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 31, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2019ALIEASSIGNED TO LIE—
Dec 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 7, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Dec 7, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 7, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 7, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 5, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 4, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 4, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 29, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 29, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 21, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 20, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2019DOCKASSIGNED TO EXAMINER—
Aug 21, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance